首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Dissolution of calcium pyrophosphate crystals by polyphosphates: an in vitro and ex vivo study
【2h】

Dissolution of calcium pyrophosphate crystals by polyphosphates: an in vitro and ex vivo study

机译:多磷酸盐溶解焦磷酸钙晶体的体外和离体研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE—To determine the dissolving ability (DA) of linear pentasodium tripolyphosphate (PSTP), cyclic trisodium metaphosphate (TSMP), polymeric sodium metaphosphate (SMP) on synthetic crystals of calcium pyrophosphate dihydrate (CPPD) and on crystalline aggregates of menisci from patients with chondrocalcinosis (CC).
METHODS—Synthetic CPPD crystals were mixed with phosphate buffered saline (PBS), which contained the different polyphosphates, for one hour at 37°C. The calcified menisci were obtained from the knees of four female patients with CPPD disease who underwent total arthroscopic meniscectomy for degenerative meniscal lesions. Meniscal cryosections and fragments were incubated in SMP (15 mg/ml PBS) at 37°C for one hour and 24 hours, respectively. Histological evaluation on meniscal samples after polyphosphate incubation was carried out by ordinary transmitted light microscopy and polarised light microscopy. The dissolution of CPPD crystals by polyphosphates was assessed by atomic absorption spectroscopy, which determined the amount of calcium liberated from synthetic crystals and meniscal fragments. Cytotoxicity of SMP was evaluated by tetrazolium salt assay and by an ultrastructural study on cultured chondrocytes.
RESULTS—SMP and PSTP showed higher DA on CPPD crystals than TSMP. Analysis of the DA values at increasing concentrations of SMP showed that a concentration of 15 mg/ml completely dissolved 2.0 mg CPPD crystals. The solution of meniscal CPPD crystals showed a significant increase of calcium concentration after three hours and 24 hours of SMP incubation (p=0.0001; Kruskal-Wallis analysis of variance) compared with fragments incubated in PBS control solution. Macroscopic and microscopic evaluation of meniscal specimens showed a notable reduction of CPPD deposits. A 50% inhibitory dose on cultured chondrocytes was reached at the maximum concentration of SMP used in this work (15 mg/ml); ultrastructural analysis did not show morphological alterations in the treated cells.
CONCLUSION—The results of this study indicate that linear polyphosphates are effective in dissolving both synthetic and ex vivo CPPD crystal aggregates. This suggests a potential therapeutic use for these molecules in the treatment of symptomatic CC.

机译:目的—确定线性三聚磷酸五钠(PSTP),环状偏磷酸三钠(TSMP),聚合偏磷酸钠(SMP)在焦磷酸钙二水合物(CPPD)的合成晶体和半月板患者半月板​​结晶聚集体上的溶解能力(DA)软骨钙化病(CC)。方法-将合成的CPPD晶体与包含不同多磷酸盐的磷酸盐缓冲盐水(PBS)混合,在37°C下放置1小时。钙化的半月板取自四名CPPD疾病的女性患者的膝盖,这些患者均接受了关节镜下半月板切除术治疗变性半月板病变。半月板冷冻切片和片段分别在37°C的SMP(15 mg / ml PBS)中孵育1小时和24小时。通过普通透射光显微镜和偏振光显微镜对多磷酸盐孵育后的半月板样品进行组织学评估。通过原子吸收光谱法评估聚磷酸盐对CPPD晶体的溶解,该光谱确定了从合成晶体和半月板碎片中释放出的钙量。通过四唑盐分析和对培养的软骨细胞的超微结构研究评估了SMP的细胞毒性。
结果-SMP和PSTP在CPPD晶体上的DA高于TSMP。在SMP浓度增加时DA值的分析表明,浓度为15 mg / ml的CPPD晶体完全溶解为2.0 mg。与在PBS对照溶液中孵育的片段相比,半月形CPPD晶体的溶液在SMP孵育3小时和24小时后显示出钙浓度的显着增加(p = 0.0001; Kruskal-Wallis方差分析)。半月板标本的宏观和微观评估显示CPPD沉积物显着减少。在这项工作中使用的最大SMP浓度(15 mg / ml),对培养的软骨细胞达到了50%的抑制剂量;超微结构分析未显示处理过的细胞的形态变化。
结论—这项研究的结果表明,线性多磷酸盐可有效溶解CPPD和体外CPPD晶体聚集体。这表明这些分子在治疗症状性CC方面有潜在的治疗用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号